Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Brambilla

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Mutation Research|February 7, 2006
Genotoxicity and carcinogenicity studies of antihypertensive agentsGiovanni Brambilla, Antonietta Martelli
Mutation Research|October 11, 2008
Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticalsGiovanni Brambilla, Antonietta Martelli
Mutation Research|December 5, 2002
Are some progestins genotoxic liver carcinogens?Giovanni Brambilla, Antonietta Martelli
Toxicology|March 24, 2004
Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogensGiovanni Brambilla, Antonietta Martelli
The Lancet. Oncology|August 7, 2003
Pharmaceutical companies often provide insufficient information about genotoxicity and carcinogenicity assaysGiovanni Brambilla, Antonietta Martelli
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Arylamine drugs: genotoxic-carcinogenic activity of NO-derivativesAntonietta Martelli, Giovanni Brambilla
Pharmacological Research|May 12, 2009
Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyreticsGiovanni Brambilla, Antonietta Martelli
The Lancet. Oncology|August 2, 2005
Keynote comment: nitrosatable drugs, cancer, and guidelines for genotoxicityGiovanni Brambilla, Antonietta Martelli
Mutation Research|December 13, 2006
Genotoxic and carcinogenic risk to humans of drug-nitrite interaction productsGiovanni Brambilla, Antonietta Martelli
Sensors (Basel, Switzerland)|November 28, 2019
Application of the Intermittency Ratio Metric for the Classification of Urban Sites Based on Road Traffic Noise EventsGiovanni Brambilla, Chiara Confalonieri, Roberto Benocci
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Mutation Research|February 7, 2006
Genotoxicity and carcinogenicity studies of antihypertensive agentsGiovanni Brambilla, Antonietta Martelli
Mutation Research|October 11, 2008
Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticalsGiovanni Brambilla, Antonietta Martelli
Mutation Research|December 5, 2002
Are some progestins genotoxic liver carcinogens?Giovanni Brambilla, Antonietta Martelli
Toxicology|March 24, 2004
Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogensGiovanni Brambilla, Antonietta Martelli
The Lancet. Oncology|August 7, 2003
Pharmaceutical companies often provide insufficient information about genotoxicity and carcinogenicity assaysGiovanni Brambilla, Antonietta Martelli
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Arylamine drugs: genotoxic-carcinogenic activity of NO-derivativesAntonietta Martelli, Giovanni Brambilla
Pharmacological Research|May 12, 2009
Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyreticsGiovanni Brambilla, Antonietta Martelli
The Lancet. Oncology|August 2, 2005
Keynote comment: nitrosatable drugs, cancer, and guidelines for genotoxicityGiovanni Brambilla, Antonietta Martelli
Mutation Research|December 13, 2006
Genotoxic and carcinogenic risk to humans of drug-nitrite interaction productsGiovanni Brambilla, Antonietta Martelli
Sensors (Basel, Switzerland)|November 28, 2019
Application of the Intermittency Ratio Metric for the Classification of Urban Sites Based on Road Traffic Noise EventsGiovanni Brambilla, Chiara Confalonieri, Roberto Benocci
Pageof 6